Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection.
about
Herpes simplex virus latency-associated transcript is a stable intronThe molecular basis of herpes simplex virus latencyOcular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?Identification of a novel latency-specific splice donor signal within the herpes simplex virus type 1 2.0-kilobase latency-associated transcript (LAT): translation inhibition of LAT open reading frames by the intron within the 2.0-kilobase LAT.EBV gene expression in an NPC-related tumour.Herpes simplex virus 1 open reading frames O and P are not necessary for establishment of latent infection in mice.Latency-associated transcripts in corneas and ganglia of HSV-1 infected rabbitsA 2.9-kilobase noncoding nuclear RNA functions in the establishment of persistent Hz-1 viral infection.The quantity of latent viral DNA correlates with the relative rates at which herpes simplex virus types 1 and 2 cause recurrent genital herpes outbreaks.The latency-associated transcript gene enhances establishment of herpes simplex virus type 1 latency in rabbits.Identification of the pseudorabies virus promoter required for latency-associated transcript gene expression in the natural host.Analysis of protein expression from within the region encoding the 2.0-kilobase latency-associated transcript of herpes simplex virus type 1Enhancer and long-term expression functions of herpes simplex virus type 1 latency-associated promoter are both located in the same regionHerpes simplex virus type 1 2-kilobase latency-associated transcript intron associates with ribosomal proteins and splicing factors.Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency.A herpes simplex virus type 1 mutant expressing a baculovirus inhibitor of apoptosis gene in place of latency-associated transcript has a wild-type reactivation phenotype in the mouse.HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.Herpes simplex virus ocular infections: current concepts of acute, latent and reactivated diseaseStructural and kinetic analyses of herpes simplex virus type 1 latency-associated transcripts in human trigeminal ganglia and in cell cultureHerpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse.A gene capable of blocking apoptosis can substitute for the herpes simplex virus type 1 latency-associated transcript gene and restore wild-type reactivation levelsRegions of the herpes simplex virus type 1 latency-associated transcript that protect cells from apoptosis in vitro and protect neuronal cells in vivo.The stable 2.0-kilobase intron of the herpes simplex virus type 1 latency-associated transcript does not function as an antisense repressor of ICP0 in nonneuronal cellsA novel herpes simplex virus type 1 transcript (AL-RNA) antisense to the 5' end of the latency-associated transcript produces a protein in infected rabbits.Herpes simplex virus type 1 latently infected neurons differentially express latency-associated and ICP0 transcripts.Herpes simplex virus 2 microRNA miR-H6 is a novel latency-associated transcript-associated microRNA, but reduction of its expression does not influence the establishment of viral latency or the recurrence phenotype.Neurovirological methods and their applications.Herpes simplex virus in the eye.Experimental investigation of herpes simplex virus latencyCharacterization of herpes simplex virus 2 primary microRNA Transcript regulationAnalysis of the promoter and cis-acting elements regulating expression of herpes simplex virus type 2 latency-associated transcriptsThe regulation of synthesis and properties of the protein product of open reading frame P of the herpes simplex virus 1 genomeThe region of the herpes simplex virus type 1 LAT gene that is colinear with the ICP34.5 gene is not involved in spontaneous reactivation.The spontaneous reactivation function of the herpes simplex virus type 1 LAT gene resides completely within the first 1.5 kilobases of the 8.3-kilobase primary transcript.Downstream regulatory elements increase acute and latent herpes simplex virus type 2 latency-associated transcript expression but do not influence recurrence phenotype or establishment of latencyPhenotypic properties of herpes simplex virus 1 containing a derepressed open reading frame P gene.A 371-nucleotide region between the herpes simplex virus type 1 (HSV-1) LAT promoter and the 2-kilobase LAT is not essential for efficient spontaneous reactivation of latent HSV-1Analysis of the 2-kilobase latency-associated transcript expressed in PC12 cells productively infected with herpes simplex virus type 1: evidence for a stable, nonlinear structureThe abundant latency-associated transcripts of herpes simplex virus type 1 are bound to polyribosomes in cultured neuronal cells and during latent infection in mouse trigeminal ganglia.The herpes simplex virus type 1 2.0-kilobase latency-associated transcript is a stable intron which branches at a guanosine
P2860
Q24564505-6DE57CEE-E76C-4E73-9718-FC652F19F7CBQ27001272-E63272A8-824C-4FA0-96A9-FE6B70CB0E43Q27021069-3D20A624-98E1-4E65-AB89-7207A1EB3379Q33238462-36115245-F0FF-4C27-9B83-DB27D63963C7Q33576708-89B4A499-8E76-4E76-ABB0-0DAB6D3274EEQ33604367-46F8EA8B-DCF7-440B-A7DF-A00E12CB75D6Q33649139-F510C6A5-8340-4A7F-A5A0-4B89E017EC13Q33782436-42D90C3B-63AC-4040-9BB9-ABC77CD94FE2Q33783025-04F7BFA0-E564-4C05-92C5-6D709184A266Q33797778-B6C0D058-3BB8-47F0-978C-B1B041B18087Q33807532-92397ED1-750C-4E7C-B7BE-F36A5B5FC0A2Q33838578-8639D548-9266-4508-B7E9-B58A7E725199Q33839884-BBCA3006-BD0F-477C-A717-842B0910AFD3Q33869971-F6B13C6F-173A-4FD5-B54C-68B5DF4C8DA1Q33931502-3A941E91-941A-4E0F-B5E7-4710F7173541Q33984275-B1ACB2CE-0D54-4EC1-B83F-E01BAB7846DDQ33995747-BF3D33A9-E6B0-41A2-A97F-417333EBE244Q34164499-36693F30-D17A-4F99-B0B6-F2EBF8A0CEB4Q34256311-11AF965D-6ECC-4C03-BE8E-5CE7E5A71C2CQ34308944-22EE82F5-59B5-4853-9FE5-94CC80D97343Q34330385-F6F78EAE-CF41-46D1-8BA3-0A81066629C5Q34358232-C31CD893-BBBE-4C95-8840-B8D14134329BQ34742782-ABEDC2F0-D728-438F-BEE4-A7D9F7DC729BQ35000720-6609D130-72FD-4250-9FA8-85B54E8E8CBBQ35024312-9C9DA345-3417-4831-BB87-AD0D323B3BFEQ35076893-1135ADF9-418E-4586-9355-B3CBAEFDC7C8Q35183104-1EE85D12-7DDB-4F87-A380-62EF349D7983Q35229787-45A97CCA-FDC4-468C-BFCB-D39F54D57BB0Q35374610-A181991B-4C4B-4966-BDF0-9A9F807084F8Q35488636-DC421134-BBEE-44ED-A603-6B4FE2FE8416Q35838719-BFC8EFAB-254A-4F17-B0E5-EE52E382DFEFQ35839814-2ABB10C7-94F0-47F7-8EA7-106FB9274110Q35853549-BE74FDB0-58E0-47EA-BE82-7DF1DB17DF2BQ35854629-58757282-D530-4422-886A-C28B14040C1BQ35856383-41250F29-6483-451C-8C1C-EEC286EF8350Q35857171-76B02D04-404F-402A-B9A4-F7AFE65023A3Q35857764-8D7F3584-A3EA-4D18-8DDA-E76A34C829B8Q35877627-6E7F56F8-968D-44A0-8F6E-5F0B62364FD3Q35880687-E47A46FF-698C-42DF-BD18-9CDEAF506828Q35885855-6D205866-3979-4603-A51C-55BAD84BDA3B
P2860
Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection.
description
1989 nî lūn-bûn
@nan
1989 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Herpes simplex virus type 1 la ...... ssential for latent infection.
@ast
Herpes simplex virus type 1 la ...... ssential for latent infection.
@en
Herpes simplex virus type 1 la ...... ssential for latent infection.
@nl
type
label
Herpes simplex virus type 1 la ...... ssential for latent infection.
@ast
Herpes simplex virus type 1 la ...... ssential for latent infection.
@en
Herpes simplex virus type 1 la ...... ssential for latent infection.
@nl
prefLabel
Herpes simplex virus type 1 la ...... ssential for latent infection.
@ast
Herpes simplex virus type 1 la ...... ssential for latent infection.
@en
Herpes simplex virus type 1 la ...... ssential for latent infection.
@nl
P2093
P2860
P1433
P1476
Herpes simplex virus type 1 la ...... ssential for latent infection.
@en
P2093
A R MacLean
J G Spivack
J H Subak-Sharpe
N W Fraser
R P Lirette
P2860
P304
P407
P577
1989-02-01T00:00:00Z